Biohaven Ltd. Common Shares
IPOClinical-stage Biopharmaceutical Company | Biohaven
Public · New Haven, United States · Founded 2013 · $493.6M raised
- Headquarters
- New Haven, Connecticut
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- biohaven.com
- Total Funding
- $493.6M
- Last Round
- $375.0M Venture RoundAug 2020
- Rounds
- 4
- Type
- Public
About
Biohaven is a clinical-stage biopharmaceutical company advancing a portfolio of more than 10 drug candidates across 6 therapeutic areas including neurology, immunology, oncology, and cardiometabolic disease. Its proprietary platforms — MoDE extracellular protein degraders, Kv7 potassium channel activators, and myostatin inhibitors — target rare and common diseases with unmet needs. Lead programs include BHV-8000 for Parkinson's disease and Alzheimer's, opakalim (BHV-7000) for epilepsy, and taldefgrobep alfa for spinal muscular atrophy and obesity.
Summary
Biohaven Ltd. Common Shares is a Biotech company based in New Haven, United States, founded in 2013. It has raised $493.6M in total across 4 rounds, most recently a $375.0M Venture Round round in Aug 2020. Investors include Oberland Capital, Sixth Street and Venrock.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2025
Sign up to see all 8 rounds
Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/biohaven-ltd-common-shares"><img src="https://indexed.vc/api/badge/company/biohaven-ltd-common-shares" alt="Biohaven Ltd. Common Shares on Indexed.vc" width="260" height="76" /></a>